DB05800InvestigationalSmall molecule
Alethine is studied in the treatment of cancer. It belongs to a family of chemicals called disulfides. It is a low molecular weight disulfide that has been shown to exhibit...
- Primary indication
- Investigated for use/treatment in blood (blood forming organ disorders, unspecified), lymphoma (unspecified), and multiple myeloma.Curator reviewed
- Formula / weight
- C10H22N4O2S2 · 294.437 g/mol (avg)
- Also known as
- Beta alethine · Beta-alanyl cysteamine disulfide · Beta-alethine · Betathine
Resolves to
Structure
InChIKey
WELIVEBWRWAGOM-UHFFFAOYSA-NSMILESNCCC(=O)NCCSSCCNC(=O)CCNWhat you can answer from here — as of April 02, 2025
Which companies are running trials of Alethine, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account